India has consistently asked China to open up its market for IT and pharmaceuticals.
n the broader market, both the BSE Midcap and Smallcap indices, were up 1.2% and 0.7% each.
Samvat 2072: Auto sector could see faster recovery
These concrete steps should include measures to address any number of pressing concerns, including prohibitively high tariffs and discriminatory forced localization requirements that are blocking US exports of a wide range of products.
The government will announce the annual Foreign Trade Policy on April 8, which will aim at giving a boost to exports of pharmaceutical, auto components and services.
Prime Minister Narendra Modi on Wednesday praised Fiji's Constitution which reflected the will of an enlightened nation, guaranteed freedoms and rights to the citizens, ensured their basic needs and empowered them.
India said on Friday that economics will be the driving factor in its relationship with China and trade between the two countries is expected to double to $20 billion by 2010.\n\n\n\n
All of Ranbaxy's India-based factories are currently banned by the FDA from exporting medicines to the United States, the company's largest market, after the regulator's inspection found violation of its so-called good manufacturing practices.
Move follows a spate of international regulatory enforcements on Indian drug firms.
The trade deficit makes up an important part of the current account deficit, which had touched an all-time high of 4.8 per cent in 2012-13.
On the profitability front, Crisil foresees a 0.5 per cent basis points y-o-y jump in EBITDA (operating profit) margins in Q2 FY15.
'This novel format of diplomacy -- the informal summit -- will not only facilitate bilateral communication and reduce miscalculations at the very top level of the two governments, but possibly open the space for China and India to speak in one voice on various issues of mutual concern,' note Feng Renjie and Ding Kun Lei
'The manufacturing sector and the capital goods industry need all the support that the government can provide, because they are working in a global market where trade restrictions are coming down every day,' says Amar Kaul.
India Inc had cheered Donald Trump's decision to scrap TPP, but now there is a growing sense that it won't really lead to positive growth in trade with the US. Subhayan Chakraborty reports.
Sensex ended strong, Tata Steel, HUL climb higher.
The board would take a decision on these applications on February 20.
He said countries should work for promoting open and inclusive cooperation for win-win outcomes.
Stick to export-focussed plays, large-caps, say analysts
RBI governor Raghuram Rajan, on Monday, said the current level of the rupee is "pretty reasonable" and any attempt to devalue it may lead to a surge in inflationary pressures and "offset any benefits"
Stocks of companies having operations and exports to Europe were the top losers.
A panel led by the secretaries of the DEA and the DIPP would conduct a quarterly review on the pending proposals.
'The government wants farmers to diversify from rice and wheat, and create another green revolution. Cannabis can play a big part in that'
The company had posted a consolidated net profit of Rs 323.31 crore (Rs 3.23 billion) in the same period last fiscal, Wockhardt Ltd said in a filing to the Bombay Stock Exchange.
FII stance, progress of monsoon, crude oil and rupee movement are likely to dictate the trend.
'India needs to adopt a more proactive policy of triggering exports to China.'
According to Chinese officials, its current investments in India stands at $1.1 billion, mostly in Gujarat.
Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter
Chidambaram promises to maintain fiscal discipline; admits inflation is an issue.
It said New Delhi increased its purchase of foreign exchange over the first three quarters of 2017 which does not appear necessary.
Corporate India's earnings in the past two quarters were largely driven by the rupee's sharp fall versus the dollar in the second quarter of this financial year.
Mankind has presence in Sri Lanka, Myanmar, Cambodia, Kenya, Uganda, Zambia and Tanzania.
India is one of the largest manufacturers of pharmaceutical products in the world with the annual production valued at over Rs 2 lakh crore.
The finance ministry is resisting pressure from other departments to cap foreign ownership of domestic drugmakers, fearing such a move would discourage potential investors, a senior ministry source said.
India's exports to China stood at $7.56 billion during the period whereas the imports have jumped to $52.26 billion in April-January
Ranbaxy Laboratories is recalling 29,790 blister packs of anti-allergy drug in the US, manufactured by its arm Ohms Laboratories, due to defective packaging.
China is on the lookout for investment pastures where its money is welcome, safe and earns a decent return. India also needs vast investment - about $1 trillion over the next 10-15 years - in infrastructure, green energy, transportation and heavy industry, says Ravi Bhoothalingam.
Ranbaxy drugs sold in the United States will be gradually rebranded as Sun Pharma treatments